aluxum/E+ via Getty Images
Zimmer Biomet (NYSE:ZBH) was upgraded at Roth Capital Partners to Buy from Neutral on the back of its recent acquisition of Monogram Technologies, a company specializing in robotics.
According to Roth analyst Jason Wittes, this acquisition addresses a significant technological gap